House committee debate turns heated over bill that would criminalize certain gender‑affirming procedures for minors
Loading...
Summary
HR 3492, the Protect Children's Innocent Act, would add criminal penalties for certain gender‑affirming procedures on minors; proponents described the bill as protecting children from irreversible harms, while opponents called it a federal overreach that would criminalize evidence‑based medical care and jeopardize vulnerable youth.
HR 3492, titled in committee as the Protect Children’s Innocent Act, drew some of the most intense exchanges of the Rules Committee hearing. Proponents described the measure as criminalizing irreversible surgeries and so‑called “chemical castration” for minors; they framed the bill as codifying a presidential executive order and aligning federal law with protections used in other countries for procedures on minors.
Representative Moore argued the bill addresses “child abuse disguised as medical intervention,” telling the committee he wanted to protect children from life‑altering medical procedures performed without full informed consent. Representative Roy and other proponents offered testimony from detransitioners and described surgeries and procedures they characterized as irreversible and harmful.
Opponents vigorously disputed that framing. Representative Jamie Raskin said the bill would expose parents, providers and clinicians to criminal prosecution, and that it would micromanage deeply personal medical decisions. “This bill would create a massive intrusion on the privacy of family medical decision making in America,” Raskin said, arguing that its provisions would criminalize standard treatments and deny medical judgment. Other Democrats warned the proposal would worsen suicide and mental‑health outcomes for transgender youth and cited studies showing increased attempts after state‑level bans.
A technical dispute emerged over the bill’s reach: proponents said the text bans permanent, irreversible procedures (which they characterized as genital mutilation or chemical castration), while opponents said the bill’s language could be read to ban puberty blockers and other treatments used in evidence‑based care for some minors. Members debated whether the measure exempts medically necessary care and whether the federal statute being amended (female genital mutilation provisions in Title 18) supplies an appropriate federal nexus.
The committee’s deliberations did not conclude in a final vote on HR 3492 itself; the Rules Committee instead adopted a structured rule that would govern floor consideration of HR 3492 and specified which amendments would be in order under the report. That procedural outcome moves the substance back to the floor for further debate.
Next steps: HR 3492’s structured‑rule status means the bill, as amended procedurally, will be eligible for floor consideration with only the amendments printed in the rules committee report available for offer, unless further procedural changes are made.
